IQVIA's research and development solution backlog at year-end was $31.5 billion, up 4.8% year over year, and the company's book-to-bill ratio for the quarter was 1.02.

More Top Stocks Daily: Go behind Wall Street’s hottest headlines with Barchart’s Active Investor newsletter. For the full fiscal 2025, analysts expect IQV to report an EPS of $10.87, up 6.1% ...